 | • レポートコード：QYR2104Z4180 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、非黒色腫皮膚がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、光線力学療法）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・非黒色腫皮膚がんの市場動向 ・企業の競争状況、市場シェア ・非黒色腫皮膚がんの種類別市場規模（化学療法、放射線療法、光線力学療法） ・非黒色腫皮膚がんの用途別市場規模（病院、診療所、外来手術センター、その他） ・非黒色腫皮膚がんの北米市場規模2016-2027（アメリカ、カナダ） ・非黒色腫皮膚がんのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・非黒色腫皮膚がんのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・非黒色腫皮膚がんの中南米市場規模2016-2027（メキシコ、ブラジル） ・非黒色腫皮膚がんの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Boehringer Ingelheim、Bristol-Myers Squibb、Eli Lilly、Roche、Merck、Novartis、Mylan、Sun Pharmaceutical、Almirall、Elekta、Varian Medical Systems、Sensus Healthcare、iCAD、Accuray、Ion Beam Applications） ・結論 |
Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts.
Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlikely to cede this commanding position anytime soon.
Market Analysis and Insights: Global Non-Melanoma Skin Cancer Market
The global Non-Melanoma Skin Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-Melanoma Skin Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-Melanoma Skin Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-Melanoma Skin Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-Melanoma Skin Cancer market.
Global Non-Melanoma Skin Cancer Scope and Market Size
Non-Melanoma Skin Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-Melanoma Skin Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Radiation Therapy
Photodynamic Therapy
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Roche
Merck
Novartis
Mylan
Sun Pharmaceutical
Almirall
Roche
Merck
Sensus Healthcare
iCAD
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Melanoma Skin Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Photodynamic Therapy
1.3 Market by Application
1.3.1 Global Non-Melanoma Skin Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-Melanoma Skin Cancer Market Perspective (2016-2027)
2.2 Non-Melanoma Skin Cancer Growth Trends by Regions
2.2.1 Non-Melanoma Skin Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non-Melanoma Skin Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Non-Melanoma Skin Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Non-Melanoma Skin Cancer Industry Dynamic
2.3.1 Non-Melanoma Skin Cancer Market Trends
2.3.2 Non-Melanoma Skin Cancer Market Drivers
2.3.3 Non-Melanoma Skin Cancer Market Challenges
2.3.4 Non-Melanoma Skin Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Melanoma Skin Cancer Players by Revenue
3.1.1 Global Top Non-Melanoma Skin Cancer Players by Revenue (2016-2021)
3.1.2 Global Non-Melanoma Skin Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Non-Melanoma Skin Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-Melanoma Skin Cancer Revenue
3.4 Global Non-Melanoma Skin Cancer Market Concentration Ratio
3.4.1 Global Non-Melanoma Skin Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Melanoma Skin Cancer Revenue in 2020
3.5 Non-Melanoma Skin Cancer Key Players Head office and Area Served
3.6 Key Players Non-Melanoma Skin Cancer Product Solution and Service
3.7 Date of Enter into Non-Melanoma Skin Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Melanoma Skin Cancer Breakdown Data by Type
4.1 Global Non-Melanoma Skin Cancer Historic Market Size by Type (2016-2021)
4.2 Global Non-Melanoma Skin Cancer Forecasted Market Size by Type (2022-2027)
5 Non-Melanoma Skin Cancer Breakdown Data by Application
5.1 Global Non-Melanoma Skin Cancer Historic Market Size by Application (2016-2021)
5.2 Global Non-Melanoma Skin Cancer Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Non-Melanoma Skin Cancer Market Size (2016-2027)
6.2 North America Non-Melanoma Skin Cancer Market Size by Type
6.2.1 North America Non-Melanoma Skin Cancer Market Size by Type (2016-2021)
6.2.2 North America Non-Melanoma Skin Cancer Market Size by Type (2022-2027)
6.2.3 North America Non-Melanoma Skin Cancer Market Size by Type (2016-2027)
6.3 North America Non-Melanoma Skin Cancer Market Size by Application
6.3.1 North America Non-Melanoma Skin Cancer Market Size by Application (2016-2021)
6.3.2 North America Non-Melanoma Skin Cancer Market Size by Application (2022-2027)
6.3.3 North America Non-Melanoma Skin Cancer Market Size by Application (2016-2027)
6.4 North America Non-Melanoma Skin Cancer Market Size by Country
6.4.1 North America Non-Melanoma Skin Cancer Market Size by Country (2016-2021)
6.4.2 North America Non-Melanoma Skin Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Non-Melanoma Skin Cancer Market Size (2016-2027)
7.2 Europe Non-Melanoma Skin Cancer Market Size by Type
7.2.1 Europe Non-Melanoma Skin Cancer Market Size by Type (2016-2021)
7.2.2 Europe Non-Melanoma Skin Cancer Market Size by Type (2022-2027)
7.2.3 Europe Non-Melanoma Skin Cancer Market Size by Type (2016-2027)
7.3 Europe Non-Melanoma Skin Cancer Market Size by Application
7.3.1 Europe Non-Melanoma Skin Cancer Market Size by Application (2016-2021)
7.3.2 Europe Non-Melanoma Skin Cancer Market Size by Application (2022-2027)
7.3.3 Europe Non-Melanoma Skin Cancer Market Size by Application (2016-2027)
7.4 Europe Non-Melanoma Skin Cancer Market Size by Country
7.4.1 Europe Non-Melanoma Skin Cancer Market Size by Country (2016-2021)
7.4.2 Europe Non-Melanoma Skin Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Non-Melanoma Skin Cancer Market Size (2016-2027)
8.2 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Type
8.2.1 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Application
8.3.1 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Region
8.4.1 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Non-Melanoma Skin Cancer Market Size (2016-2027)
9.2 Latin America Non-Melanoma Skin Cancer Market Size by Type
9.2.1 Latin America Non-Melanoma Skin Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Non-Melanoma Skin Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Non-Melanoma Skin Cancer Market Size by Type (2016-2027)
9.3 Latin America Non-Melanoma Skin Cancer Market Size by Application
9.3.1 Latin America Non-Melanoma Skin Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Non-Melanoma Skin Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Non-Melanoma Skin Cancer Market Size by Application (2016-2027)
9.4 Latin America Non-Melanoma Skin Cancer Market Size by Country
9.4.1 Latin America Non-Melanoma Skin Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Non-Melanoma Skin Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Melanoma Skin Cancer Market Size (2016-2027)
10.2 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Type
10.2.1 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Application
10.3.1 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Country
10.4.1 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Non-Melanoma Skin Cancer Introduction
11.1.4 Boehringer Ingelheim Revenue in Non-Melanoma Skin Cancer Business (2016-2021)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Non-Melanoma Skin Cancer Introduction
11.2.4 Bristol-Myers Squibb Revenue in Non-Melanoma Skin Cancer Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Non-Melanoma Skin Cancer Introduction
11.3.4 Eli Lilly Revenue in Non-Melanoma Skin Cancer Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Non-Melanoma Skin Cancer Introduction
11.4.4 Roche Revenue in Non-Melanoma Skin Cancer Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Non-Melanoma Skin Cancer Introduction
11.5.4 Merck Revenue in Non-Melanoma Skin Cancer Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Non-Melanoma Skin Cancer Introduction
11.6.4 Novartis Revenue in Non-Melanoma Skin Cancer Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Non-Melanoma Skin Cancer Introduction
11.7.4 Mylan Revenue in Non-Melanoma Skin Cancer Business (2016-2021)
11.7.5 Mylan Recent Development
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Company Details
11.8.2 Sun Pharmaceutical Business Overview
11.8.3 Sun Pharmaceutical Non-Melanoma Skin Cancer Introduction
11.8.4 Sun Pharmaceutical Revenue in Non-Melanoma Skin Cancer Business (2016-2021)
11.8.5 Sun Pharmaceutical Recent Development
11.9 Almirall
11.9.1 Almirall Company Details
11.9.2 Almirall Business Overview
11.9.3 Almirall Non-Melanoma Skin Cancer Introduction
11.9.4 Almirall Revenue in Non-Melanoma Skin Cancer Business (2016-2021)
11.9.5 Almirall Recent Development
11.10 Elekta
11.10.1 Elekta Company Details
11.10.2 Elekta Business Overview
11.10.3 Elekta Non-Melanoma Skin Cancer Introduction
11.10.4 Elekta Revenue in Non-Melanoma Skin Cancer Business (2016-2021)
11.10.5 Elekta Recent Development
11.11 Varian Medical Systems
11.11.1 Varian Medical Systems Company Details
11.11.2 Varian Medical Systems Business Overview
11.11.3 Varian Medical Systems Non-Melanoma Skin Cancer Introduction
11.11.4 Varian Medical Systems Revenue in Non-Melanoma Skin Cancer Business (2016-2021)
11.11.5 Varian Medical Systems Recent Development
11.12 Sensus Healthcare
11.12.1 Sensus Healthcare Company Details
11.12.2 Sensus Healthcare Business Overview
11.12.3 Sensus Healthcare Non-Melanoma Skin Cancer Introduction
11.12.4 Sensus Healthcare Revenue in Non-Melanoma Skin Cancer Business (2016-2021)
11.12.5 Sensus Healthcare Recent Development
11.13 iCAD
11.13.1 iCAD Company Details
11.13.2 iCAD Business Overview
11.13.3 iCAD Non-Melanoma Skin Cancer Introduction
11.13.4 iCAD Revenue in Non-Melanoma Skin Cancer Business (2016-2021)
11.13.5 iCAD Recent Development
11.14 Accuray
11.14.1 Accuray Company Details
11.14.2 Accuray Business Overview
11.14.3 Accuray Non-Melanoma Skin Cancer Introduction
11.14.4 Accuray Revenue in Non-Melanoma Skin Cancer Business (2016-2021)
11.14.5 Accuray Recent Development
11.15 Ion Beam Applications
11.15.1 Ion Beam Applications Company Details
11.15.2 Ion Beam Applications Business Overview
11.15.3 Ion Beam Applications Non-Melanoma Skin Cancer Introduction
11.15.4 Ion Beam Applications Revenue in Non-Melanoma Skin Cancer Business (2016-2021)
11.15.5 Ion Beam Applications Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Non-Melanoma Skin Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Photodynamic Therapy
Table 5. Global Non-Melanoma Skin Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Non-Melanoma Skin Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Non-Melanoma Skin Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Non-Melanoma Skin Cancer Market Share by Regions (2016-2021)
Table 9. Global Non-Melanoma Skin Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Non-Melanoma Skin Cancer Market Share by Regions (2022-2027)
Table 11. Non-Melanoma Skin Cancer Market Trends
Table 12. Non-Melanoma Skin Cancer Market Drivers
Table 13. Non-Melanoma Skin Cancer Market Challenges
Table 14. Non-Melanoma Skin Cancer Market Restraints
Table 15. Global Non-Melanoma Skin Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Non-Melanoma Skin Cancer Market Share by Players (2016-2021)
Table 17. Global Top Non-Melanoma Skin Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Melanoma Skin Cancer as of 2020)
Table 18. Ranking of Global Top Non-Melanoma Skin Cancer Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Non-Melanoma Skin Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Non-Melanoma Skin Cancer Product Solution and Service
Table 22. Date of Enter into Non-Melanoma Skin Cancer Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Non-Melanoma Skin Cancer Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Non-Melanoma Skin Cancer Revenue Market Share by Type (2016-2021)
Table 26. Global Non-Melanoma Skin Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Non-Melanoma Skin Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Non-Melanoma Skin Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Non-Melanoma Skin Cancer Revenue Market Share by Application (2016-2021)
Table 30. Global Non-Melanoma Skin Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Non-Melanoma Skin Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Non-Melanoma Skin Cancer Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Non-Melanoma Skin Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Non-Melanoma Skin Cancer Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Non-Melanoma Skin Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Non-Melanoma Skin Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Non-Melanoma Skin Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Non-Melanoma Skin Cancer Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Non-Melanoma Skin Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Non-Melanoma Skin Cancer Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Non-Melanoma Skin Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Non-Melanoma Skin Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Non-Melanoma Skin Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Non-Melanoma Skin Cancer Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Non-Melanoma Skin Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Non-Melanoma Skin Cancer Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Non-Melanoma Skin Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Non-Melanoma Skin Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Non-Melanoma Skin Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Non-Melanoma Skin Cancer Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Non-Melanoma Skin Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Non-Melanoma Skin Cancer Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Non-Melanoma Skin Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Non-Melanoma Skin Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Non-Melanoma Skin Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Non-Melanoma Skin Cancer Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Non-Melanoma Skin Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Non-Melanoma Skin Cancer Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Non-Melanoma Skin Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Non-Melanoma Skin Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Non-Melanoma Skin Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 62. Boehringer Ingelheim Company Details
Table 63. Boehringer Ingelheim Business Overview
Table 64. Boehringer Ingelheim Non-Melanoma Skin Cancer Product
Table 65. Boehringer Ingelheim Revenue in Non-Melanoma Skin Cancer Business (2016-2021) & (US$ Million)
Table 66. Boehringer Ingelheim Recent Development
Table 67. Bristol-Myers Squibb Company Details
Table 68. Bristol-Myers Squibb Business Overview
Table 69. Bristol-Myers Squibb Non-Melanoma Skin Cancer Product
Table 70. Bristol-Myers Squibb Revenue in Non-Melanoma Skin Cancer Business (2016-2021) & (US$ Million)
Table 71. Bristol-Myers Squibb Recent Development
Table 72. Eli Lilly Company Details
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Non-Melanoma Skin Cancer Product
Table 75. Eli Lilly Revenue in Non-Melanoma Skin Cancer Business (2016-2021) & (US$ Million)
Table 76. Eli Lilly Recent Development
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Non-Melanoma Skin Cancer Product
Table 80. Roche Revenue in Non-Melanoma Skin Cancer Business (2016-2021) & (US$ Million)
Table 81. Roche Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Non-Melanoma Skin Cancer Product
Table 85. Merck Revenue in Non-Melanoma Skin Cancer Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Non-Melanoma Skin Cancer Product
Table 90. Novartis Revenue in Non-Melanoma Skin Cancer Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Mylan Company Details
Table 93. Mylan Business Overview
Table 94. Mylan Non-Melanoma Skin Cancer Product
Table 95. Mylan Revenue in Non-Melanoma Skin Cancer Business (2016-2021) & (US$ Million)
Table 96. Mylan Recent Development
Table 97. Sun Pharmaceutical Company Details
Table 98. Sun Pharmaceutical Business Overview
Table 99. Sun Pharmaceutical Revenue in Non-Melanoma Skin Cancer Business (2016-2021) & (US$ Million)
Table 100. Sun Pharmaceutical Recent Development
Table 101. Almirall Company Details
Table 102. Almirall Business Overview
Table 103. Almirall Non-Melanoma Skin Cancer Product
Table 104. Almirall Revenue in Non-Melanoma Skin Cancer Business (2016-2021) & (US$ Million)
Table 105. Almirall Recent Development
Table 106. Elekta Company Details
Table 107. Elekta Business Overview
Table 108. Elekta Non-Melanoma Skin Cancer Product
Table 109. Elekta Revenue in Non-Melanoma Skin Cancer Business (2016-2021) & (US$ Million)
Table 110. Elekta Recent Development
Table 111. Varian Medical Systems Company Details
Table 112. Varian Medical Systems Business Overview
Table 113. Varian Medical Systems Non-Melanoma Skin Cancer Product
Table 114. Varian Medical Systems Revenue in Non-Melanoma Skin Cancer Business (2016-2021) & (US$ Million)
Table 115. Varian Medical Systems Recent Development
Table 116. Sensus Healthcare Company Details
Table 117. Sensus Healthcare Business Overview
Table 118. Sensus Healthcare Non-Melanoma Skin Cancer Product
Table 119. Sensus Healthcare Revenue in Non-Melanoma Skin Cancer Business (2016-2021) & (US$ Million)
Table 120. Sensus Healthcare Recent Development
Table 121. iCAD Company Details
Table 122. iCAD Business Overview
Table 123. iCAD Non-Melanoma Skin Cancer Product
Table 124. iCAD Revenue in Non-Melanoma Skin Cancer Business (2016-2021) & (US$ Million)
Table 125. iCAD Recent Development
Table 126. Accuray Company Details
Table 127. Accuray Business Overview
Table 128. Accuray Non-Melanoma Skin Cancer Product
Table 129. Accuray Revenue in Non-Melanoma Skin Cancer Business (2016-2021) & (US$ Million)
Table 130. Accuray Recent Development
Table 131. Ion Beam Applications Company Details
Table 132. Ion Beam Applications Business Overview
Table 133. Ion Beam Applications Non-Melanoma Skin Cancer Product
Table 134. Ion Beam Applications Revenue in Non-Melanoma Skin Cancer Business (2016-2021) & (US$ Million)
Table 135. Ion Beam Applications Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Melanoma Skin Cancer Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Photodynamic Therapy Features
Figure 5. Global Non-Melanoma Skin Cancer Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Non-Melanoma Skin Cancer Report Years Considered
Figure 11. Global Non-Melanoma Skin Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Non-Melanoma Skin Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Non-Melanoma Skin Cancer Market Share by Regions: 2020 VS 2027
Figure 14. Global Non-Melanoma Skin Cancer Market Share by Regions (2022-2027)
Figure 15. Global Non-Melanoma Skin Cancer Market Share by Players in 2020
Figure 16. Global Top Non-Melanoma Skin Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Melanoma Skin Cancer as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Non-Melanoma Skin Cancer Revenue in 2020
Figure 18. Global Non-Melanoma Skin Cancer Revenue Market Share by Type (2016-2021)
Figure 19. Global Non-Melanoma Skin Cancer Revenue Market Share by Type (2022-2027)
Figure 20. North America Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Non-Melanoma Skin Cancer Market Share by Type (2016-2027)
Figure 22. North America Non-Melanoma Skin Cancer Market Share by Application (2016-2027)
Figure 23. North America Non-Melanoma Skin Cancer Market Share by Country (2016-2027)
Figure 24. United States Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Non-Melanoma Skin Cancer Market Share by Type (2016-2027)
Figure 28. Europe Non-Melanoma Skin Cancer Market Share by Application (2016-2027)
Figure 29. Europe Non-Melanoma Skin Cancer Market Share by Country (2016-2027)
Figure 30. Germany Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Non-Melanoma Skin Cancer Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Non-Melanoma Skin Cancer Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Non-Melanoma Skin Cancer Market Share by Region (2016-2027)
Figure 40. China Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Non-Melanoma Skin Cancer Market Share by Type (2016-2027)
Figure 48. Latin America Non-Melanoma Skin Cancer Market Share by Application (2016-2027)
Figure 49. Latin America Non-Melanoma Skin Cancer Market Share by Country (2016-2027)
Figure 50. Mexico Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Non-Melanoma Skin Cancer Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Non-Melanoma Skin Cancer Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Non-Melanoma Skin Cancer Market Share by Country (2016-2027)
Figure 56. Turkey Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Non-Melanoma Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2016-2021)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2016-2021)
Figure 65. Mylan Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2016-2021)
Figure 66. Sun Pharmaceutical Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2016-2021)
Figure 67. Almirall Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2016-2021)
Figure 68. Elekta Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2016-2021)
Figure 69. Varian Medical Systems Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2016-2021)
Figure 70. Sensus Healthcare Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2016-2021)
Figure 71. iCAD Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2016-2021)
Figure 72. Accuray Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2016-2021)
Figure 73. Ion Beam Applications Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界の非黒色腫皮膚がん治療市場規模・現状・予測（2021年-2027年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…- 世界の黒色腫がん市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Melanoma Cancer Market The global Melanoma Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a bri…
- 世界の黒色腫がん診断市場規模・現状・予測（2021年-2027年） Melanoma is a type of skin cancer developing from pigment-containing cells known as melanocytes. Melanoma cancer diagnostics is to diagnose melanoma with biopsy. During a biopsy, all or the part of mole or growth over the skin is removed to test and analyze the sample. Common biopsy procedures used …
- 世界の皮膚がん治療薬市場規模・現状・予測（2021年-2027年） On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the exte…
- 世界の黒色腫市場規模・現状・予測（2021年-2027年） Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are mo…